Top Markets
#1 Black Phoenix Black Phoenix +17,818.82%
#2 Cash Dog in Hood Cash Dog in Hood +6,488.56%
#3 up up +70.00%
#4 AgentFun.AI AgentFun.AI +54.83%
#5 Quai Network Quai Network +41.96%
#6 Arrow Arrow +38.24%
#7 Octra Octra +34.92%
#8 B3 (Base) B3 (Base) +32.40%
#9 Derive Derive +32.29%
#10 Nockchain Nockchain +29.33%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Rangering i aksjer #15063
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Aksjekurs
$4.66
Markedsverdi
$43.92M
Endring (1 dag)
-0.63%
Endring (1 år)
338.04%
Land
FR
Handel Theranexus Société Anonyme (ALTHX)

Kategori

Healthcare
P/B-forhold for Theranexus Société Anonyme (ALTHX)
P/B-forhold per July 2026 TTM: 23.01
Ifølge Theranexus Société Anonyme sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 23.01. Ved slutten av 2023 hadde selskapet et P/B-forhold på 3.91.
P/B-historikk for Theranexus Société Anonyme fra 2015 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
2026 (TTM) 23.01 -872.06%
2024 -2.98 -176.13%
2023 3.91 140.89%
2022 1.62 -32.16%
2021 2.39 -67.52%
2020 7.37 537.01%
2019 1.16 -73.36%
2018 4.34 72.54%
2017 2.52 -98.37%
2016 154.33 1,766.00%
2015 8.27 0.00%
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 6.8826 -70.09%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5189 -71.67%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.0637 -91.03%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.5808 -80.09%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.7629 -66.26%
NL